当前位置: X-MOL 学术Leukemia › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection.
Leukemia ( IF 11.4 ) Pub Date : 2019-12-13 , DOI: 10.1038/s41375-019-0687-2
Marco Frigeni 1, 2 , Caroline Besson 3 , Carlo Visco 4 , Helene Fontaine 5 , Maria Goldaniga 6 , Marcella Visentini 7 , Alessandro Pulsoni 8 , Harrys A Torres 9 , Jan Peveling-Oberhag 10, 11 , Roberto Rossotti 12 , Francesco Zaja 13 , Luigi Rigacci 14 , Michele Merli 15 , Céline Dorival 16 , Camille Alric 17 , Francesco Piazza 18 , Massimo Gentile 19 , Angela Ferrari 20 , Mario Pirisi 21 , Luca Nassi 22 , Sara Rattotti 2 , Annamaria Frustaci 23 , Michele Milella 24 , Emanuele Cencini 25 , Irene Defrancesco 1 , Virginia Valeria Ferretti 1 , Raffaele Bruno 26, 27 , Olivier Hermine 28, 29 , Luca Arcaini 1, 2
Affiliation  



中文翻译:

与基于干扰素的抗病毒方案相比,无干扰素是与丙型肝炎病毒感染相关的B细胞淋巴增生性疾病的一线治疗。

更新日期:2019-12-17
down
wechat
bug